Hays County Historic Court House. Star file photo
The Hays County Commissioners Court authorized a resolution establishing a new county district court and approved its 2020 fiscal year report at its March 30 meeting.
The court unanimously approved a resolution calling for the creation of an additional district court within Hays County to assist with the growing population and court system caseload. The district court will go into effect on Sept. 1, 2022.
The resolution came after District 45 State Rep. Erin Zwiener introduced various Texas Legislature bills and requested the court to submit its feedback and resolutions on the bills, one of which asked for the creation of the new court.
Daily Monitor
Tuesday March 16 2021
Summary
Work plans have been revised with more focus being put on emerging risks such as health and safety of employees, cybersecurity, risk management, business continuity, and cost reduction.
Advertisement
The Covid-19 pandemic has had unprecedented effects on individuals, businesses, governments and society. Accountants have felt the pinch too and this caused them not only to revisit the roles they play at their workplaces but also change the way they perform their duties.
The pandemic caused organisations to introduce remote working to minimise its effects on the employees. Many accountants had to quickly adapt to new technologies to navigate through the challenges created by the pandemic.
Katapult Announces Chris Towers as Chief Accounting Officer yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
(2)
DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): AGM/EGM
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Announces Nominations to Reappoint Ulrich Dauer as CEO and to Appoint Florian Schmid as CFO
29.01.2021 / 18:09
Vivoryon Therapeutics N.V. Announces Nominations
to Reappoint Ulrich Dauer as CEO and to Appoint Florian Schmid as CFO
HALLE (SAALE) / MUNICH, GERMANY, 29 January 2021 - the Board of Directors (
Board) of Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (
Vivoryon) announced today that it will hold an Extraordinary General Meeting of Shareholders (
EGM) on Friday, March 12, 2021. The EGM will take place virtually.
The EGM agenda, explanatory notes and terms of participation have been made public and are available as of January 29, 2021 on the Vivoryon website https://www.vivoryon.com/extraordinary-general-meeting-2021/. Vivoryon shareholders are invited to consult the company website in order to obtain current information on